This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.

Read the full coverage here:

Single-use bronchoscope receives FDA clearance

Moderna COVID-19 vaccine safe, efficacious in adolescents

Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study

FDA allows third dose of COVID-19 vaccine for immunocompromised patients

CMS nixes 'most-favored nation' pricing model for Medicare Part B

References:

Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.

CMS proposed rule.

Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.

Press Release.

Press Release.